The issue of nosocomial infection caused by Klebsiella pneumoniae blaNDM-type by Mironenko, Olga V. et al.
© Санкт-Петербургский государственный университет, 2020





The issue of nosocomial infection caused 
by Klebsiella pneumoniae blaNDM-type
O. V. Mironenko1,2, V. V. Selnitseva3, L. A. Soprun2, E. N. Shmushkevich3, 
A. A. Alekseev1, A. S. Ivanov1, A. A. Тоvanova1
1 North-Western State Medical University named after I. I. Mechnikov, 
41, Kirochnaya ul., St. Petersburg, 191015, Russian Federation
2 St. Petersburg State University, 
7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
3 St. Petersburg State City Hospital no. 2, 
5, Uchebny per., St. Petersburg, 194354, Russian Federation
For citation: Mironenko O. V., Selnitseva V. V., Soprun L. A., Shmushkevich E. N., Alekseev A. A., 
Ivanov  A. S., Тоvanova A. A. The issue of nosocomial infection caused by Klebsiella pneumoniae 
blaNDM-type. Vestnik of Saint Petersburg University. Medicine, 2020, vol. 15, issue 2, pp. 124–133.
https://doi.org/10.21638/spbu11.2020.204
The article presents information about circulating isolates Klebsiella pneumoniae in a hospital 
megapolis with properties of hypervirulence and simultaneous multiresistance. The resulting 
K. pneumonia isolates are of particular importance due to the emergence of resistance to almost 
all β-lactams due to the presence of carbapenemase metal-β-lactamase. Furthermore, the isolated 
strains producing carbapenemases possess mechanisms of resistance to a wide range of antimi-
crobial preparations, and the types of infectious process caused by carbapenemazo-producing 
enterobacteries are characterized by a high lethality level. Microbiological, biochemical, bio-
physical, molecular-genetic, biological, bioinformational and statistical methods of research were 
used in the work. A prospective method was used to identify the source of the infections. In the 
first stage, a microbiological study was carried out on biomaterials obtained from patients treat-
ed in a hospital in Saint Petersburg. After a microbiological study, 52 isolates of K. pneumoniae 
were obtained, 53.8 % of isolates had a hypermucoid phenotype and 98 % had carbapenemases: 
blaNDM type — 49 (92 %), blaNDM+OXA-48-like — 3 (8 %). Isolates with two new phenotypes 
have been isolated (no. 2511 and no. 2512). Isolates of no. 2512 LD50 had 10*2 BAC/ml, and 
plasmids such as Incfib(Mar), Inchi1b, and Incr were also found, with Incr-A plasmid emitted 
encoding resistance to fluoroquinolone: aac(6’)-Ib-cr and to β-lactam antibiotics: blaTEM-1B. 
The described data confirm the opinions of the researchers about the possible formation of a new 
“super pathogen” — instantaneously hypervirulent and plural resistant strain of K. pneumoniae.
Keywords: K. pneumonia blaNDM, nosocomial infection, epidemiological process, carbapen-
emaza, hypervirulence. 
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Introduction
According to WHO data, carbapenem-resistant enterobacteria are the main causes of 
nosocomial infections by the beginning of 2020. Enterobacteria due to increased morbidity 
and mortality among hospitalized carbapeneme patients is considered the last line of treat-
ment for Enterobacteria infections and resistance to them is a major problem for clinicians.
As is known, the group “ESKAPE” includes antibiotic-resistant pathogens (Enterococ-
cus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseu-
domonas aeruginosa and Enterober spp.), including K. pneumoniae (Santajit, Indrawattana, 
2016) [1]. In the Russian Federation, as in the rest of the world, K. pneumoniae are current 
hospital pathogens [2–4] and cause a wide range of pathologies in humans: sepsis, bacte-
ria, respiratory infections, infections of the urinary system, gastro-intestinal lesions, eyes, 
primary abscesses, etc. [5–7].
Starting in the second half of the 1990s, carbapenemase spread became a problem in 
several European countries, with P. aeruginosa being the most common causative agent. 
Less than 10 years later, in the 2000s, K. pneumoniae began an epidemic spread in Greece, 
containing integrated metal-β-lactamases from Verona (Verona integron-ded metallo-
β-lactamase — VIM), followed by carbapenemases (Klebsiella pneumoniae carbabapen-
emase — KPC).
Carbapenemaza is the most common species of K. pneumoniae among enterobacte-
ria in Europe today. Currently in Greece and Italy, about 60 and 15 % (respectively) of all 
invasive K. pneumoniae are insensitive to carbapenemes [1; 8; 9]. Enterobacteria remains 
the main cause of death and complications of major diseases among patients in hospital.
In addition to the carbapen listed above, one of the major problems of the past 
few years among nosocomial infections is carbapenemase from New Delhi (New Delhi 
metallo-β-lactamase). Metal-βlactamases (MBL) from New Delhi spread epidemiologi-
cally to the Indian subcontinent and the Middle East, which were then introduced to Eu-
rope. The distribution of OXA-48-like enzymes in a number of European countries began 
in the form of individual outbreaks, and continued rapidly [10–12].
There are quite a few K. pneumoniae classifications. This article will be guided by the 
epidemiological principle based on the evolutionary approach of isolating classical and 
hypervirulent klebsiell strains [13].
The classical K. pneumoniae causes diseases in infants and the elderly, as well as in 
persons with reduced immunity, who have a large number of chronic pathologies and 
related diseases [14]. Characterized by the presence of genes of beta-lactamase (CTX-M, 
TEM-, OXA-48, NDM- and KPC-types), integrons of genetic determinants, which deter-
mine their antibacterial characteristics and the distribution among microflora of treat-
ment and prevention institutions [15]. The domestic authors describe multi-stable clinical 
strains of Klebsiell to cephalosporins and carbapenemes, on the territory of the Russian 
Federation [3; 5; 10; 16].
With regard to the second species of K. pneumoniae, these hypervirulents are capable, 
causing severe, with the frequency of fatal outcome 3–55 %, diseases in people with normal 
immunity [9; 12]. The primary excretive abscess of the liver followed by the metastasiza-
tion of the agent from the site of infection to other organs and tissues is a manifestation of 
hypervirulent strains, first described in Asia (India) [17]. It is known that it is the genetic de-
terminant that defines the property of hypermucoity. So hypervirulent K. pneumoniae more 
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often than classical strains are characterized by a hypermucoid phenotype [8; 18], with mo-
lecular systems of trivalent iron absorption [12; 13], with a recycling system of alloantoine 
[19], with synthesis of smooth lipopolysaccharide and polysaccharide capsule [10; 15] and 
with the presence of type I fimbrial [16]. Multiresistant classical K. pneumoniae syvens ST11, 
ST14, ST15, ST35, ST36, ST147, ST258, ST309, ST1107 and K1-K78 types [13; 20] and hy-
pervirulent strains K. pneumoniae with ST23, ST29, ST65, ST86, ST268, ST375, ST412 and 
ST420 [13; 19; 20] and K1, K2, and rarely K5, K20, K54 and K57 types [13; 16; 20].
It is most often mobile genetic elements (plasmids) that are the basis of antibiotic re-
sistance and virulence in klebsiells, as well as in other bacteria. In South Korea, the strains 
K1 ST23 with the epidemic gene beta-lactamase: cephalosporinase blaCTX-M-15, which 
have been isolated from the hypervirulent K. pneumoniae [17], have been described. K. pneu-
moniae multilocus systematization allows for the detection of pathogen epidemic genetic 
lines, their distribution in the world, and the assessment of the contribution of different 
genetic lines to the spread of genetic determinants of antibiotic resistance and virulence.
For example, the hypervirulent evolutionary branch is associated with the isolates 
K. pneumoniae of the world’s most common clonal CC23 complex (ST23 and ST218 se-
quels). A high degree of virulence for humans and laboratory animals is noted for the 
ST86 and ST65 sequel types. A wide range of ABP resistance can be found in K. pneu-
moniae of other genetic lines: CC258, CC11, CC15, and CCC14.
In a 2013 study in China, K. pneumoniae ST15 dominated the isolates isolated in 
306  hospitals, which included pan-resistant strains that caused lung infections, kidney 
dysfunction, and heart failure. It is noted that K. pneumoniae ST15 is widely distributed in 
Denmark, Hungary, Korea, Malaysia, Singapore and Taiwan. Isolates of ST11 are also com-
mon in China, while the clebsiells of the “hybrid” ST258, formed from ST11 and ST442, are 
widely represented in North and Latin America, as well as in some countries of Europe.
In other countries, there have also been reports of the acquisition of hypervirulent 
characteristics of K. pneumoniae: Argentina — strains of K1 ST23 with carbapenemase 
gene K1 blaKPC–2 [21], China — strains of new ST1797 with genome blaKPC–2 [19], 
France — strains of K2 ST86 with genome blaCTX-M-3 [17]. In 2017, the Russian Fed-
eration described a case of meningitis in the neonatal ward of Kazan, caused by a hyper-
mucoid, rmpA-positive strain of K. pneumoniae producing unidentified beta lactamase of 
the extended spectrum [10; 22]. In 2017, China recorded the acquisition of pLVPK-type 
plasmid virulence with multiresistant hospital strains K47 K. pneumoniae ST11 [9; 22].
In 2017, China recorded the acquisition of pLVPK-type plasmid virulence with mul-
tiresistant hospital strains K47  K. pneumoniae ST11  [9; 22]. Hospital K. pneumoniae in 
China have multiple drug resistance of 61.4 %, 2.0 % extreme drug resistance and 1.8 % 
resistance to all antibiotics used.
For K. pneumoniae ST11  and ST258, KPC- and NDM-type carbapenemases are 
often common. Due to the active study of K. pneumoniae, new sequins of isolates are 
discovered every year. In the large-scale study Wang et al., in 2013, seven new gene al-
leles of “household” Klebsiell and 24 new sequins-s were described type, in Venezuela in 
2017 — 3 new sequels of type have been identified, in Germany a new highly virulent 
ST2398 has been described. In Germany, the new ST2398 has been described. The de-
scribed data confirm the opinions of the researchers about the possible formation of a 
new “super pathogen” — a hypervirulent and simultaneously multi-resistant strain of 
K. pneumoniae.
Вестник СПбГУ. Медицина. 2020. Т. 15. Вып. 2 127
The purpose of our research was to study the molecular-genetic properties and regu-
larities of epidemiological propagation in a multi-functional stationary strain of K. pneu-
monia, which is polyresistant to antibacterial drugs and hypervirulence.
Materials and methods of research
Microbiological, biochemical, biophysical, molecular-genetic, biological, bioinfor-
matic and statistical research methods have been used to achieve this goal. A prospective 
method was used to identify the source of the infections.
In the first stage, a microbiological study was carried out on biomaterials obtained 
from patients treated in a multidisciplinary hospital in Saint Petersburg. The following 
biomaterials were obtained for the study materials: BAL 14  (27 %), separated from the 
ear 1 (2 %), conjunctiva 3 (6 %), unknown 7 (13 %), sputum 15 (29 %), tracheal aspirate 2 
(4 %), urine 9 (17 %), severable from the wound 1 (2 %).
The composition of biomaterial samples has been estimated using two methods: a 
real-time polymerase chain reaction (PCR-PB) and a meagenomic study analysing gene 
sequences to determine the quantitative content of bacteria, Percentage representation, 
alpha and beta diversity. Bacteria were cultivated in dense and liquid nutrient media, stor-
ing 15 % glycerine at minus 70 °C. The species was identified using VITEK–2 Compact 
(Biomerieux, France) and MALDI-TOF Biotyper (Bruker, Germany). Forty-six cases of 
PCR isolated K. pneumonia patients were analysed.
Preparation of the DNA matrix for the polymerase chain reaction. Cell thermolytes 
were used as the matrix for PCR. The bacteriological loop of the nocturnal bacterial cul-
ture was suspended in 0.1 ml of the lyzing solution (0.25 % SDS, 0.05 M Naoh) to a con-
centration of 108–109 MEC/ml in test tubes with a capacity of 1.5 ml of type Eppendorf. 
The samples were warmed up at 98-100 °C on a water bath or in a solid thermostat, with 
0.9 ml of deionized water added to each test tube, the samples were centrifuged at 19,000 g 
for 2 minutes at a temperature of 4 °S. The supernatant was sampled into sterile microfab-
rics and used as a 1–2 um matrix for the PCR reaction.
The commercial Genejet Plasmid Miniprep Kit (Thermo Fisher Scientific, Waltham, 
USA) was used to extract plasmid DNA from the bacteria according to the manufacturer’s 
instructions. Whose principle is based on the alkaline lysis of deposited bacterial cells by 
centrifuging in the presence of SDS with further lysate neutralization, the removal of de-
bris with SDS with the aid of centrifuging. Adsorption of plasmid DNA on a column with 
a membrane based on silica — gel and its evaporation from the membrane of the column 
after removal of impurities by double flushing. Plasmid profiles were visualized with an 
electrophoresis of 0.7 % agarosis gel.
In accordance with guidance no. 4.2. 1890-04 determined the sensitivity of bacte-
ria to BPA by micro-prospecting in Muller-Hinton broth and disco by diffusion meth-
od using commercial discs in 96-lunar tablets for the following antibiotics: cefoaxim, 
cephepim, ceftazidim, gentamicin, Imipenem, Meropeem, trimethodium-sulfone-
thoxazole, thihecycline, polymyxin B, ciprofloxacin, ceftazidim-avibakts, aztreonam-
avibakts. The string test was used to determine the hypermucoidality of K. pneumoniae 
cultures [9; 22].
Primer-specific PCR has been used to determine K. pneumoniae strains of genetic 
determinants of resistance to BDP, genes associated with virulence and capsule types in 
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the genomes of Enterobacteriaceae bacteria. Carbapenemase genes have been detected 
by PCR using the Amplysens®mdr KPC/OXA-48-FL(blaKPC, blaOXA-48-like) and 
Amplysens®mdr MBL-FL (blaVIM, blaIMP, blaNDM) sets (Interlabservice). Production 
of oligonucleotides and sequencing of DNA sequences using the Sanger method.
The data were then evaluated using statistical and epidemiological methods. De-
scriptive statistics included calculations of arithmetic mean and standard deviation 
(Mean SD), median and 1st and 3rd quartiles (Median, [Q1;Q3]), and indications of 
minimum and maximum values (min-max). Based on the regression coefficients for 
the best model, the morbidity rate (incidence rate, IRR) and its 95 % confidence interval 
(CI) were calculated. The result was considered statistically significant when the prob-
abilities of a first genus error (p) were less than 0.05. For p = 0.005, the results were 
considered extremely significant.
Results
52 isolates of K. pneumonia have been isolated. The age group of investigated and pos-
sible sources of infection was as follows: 24–44 years — 9 %, 45–60 years — 23 %, 61–70 — 
21 %, 71–80 — 20 %, over 81 — 27 %. (Fig. 1). 
In 57 % of cases, the main diagnosis is related to the pathology of the cardiovascular 
system, 23 % to the respiratory system, 9 % to the endocrine system and 7 % to the urinary 
system. In 43.18 % of the cases, the fatal outcome was achieved.
In order to identify the mechanisms of transmission of the infection, a type of in-
tervention was established: 34 % — endoscopic manipulation, 11 % — cavity operation, 
20 % — tracheostoma (Fig. 2).
52 % of patients were transferred between different wards. Valuable in the context of 
the referral mechanism is the determination of the number of interventions performed 
per patient: the highest in 5 operations in 33 % of cases, 27 % (4 interventions), 20 % (3), 
13 % (2), 7 % (1).
In order to study the characteristics of the source of the infection, it was found that 
cephalosporins were prescribed in 30 % of cases, fluoroquinolone was prescribed in 17 % 
of cases, and the following antibacterial preparations were taken in 12 % of cases: nitro-
moidazole, aminoglycosides, carbapenemes (Fig. 3). 
Of these, 28 isolates (53.8 %) had a hypermucoid phenotype, while the rest had no 
phenotypic reaction of 24  (46.2 %). The specified carbapenemase types are: blaNDM 
type — 49 (92 %), blaNDM+OXA-48-like — 3 (6 %), negative — 1 (2 %). Most carbap-
enemase-producing bacteria are resistant to extended-spectrum oxyminicephalo sporins.
By analyzing the hydrolysis of carbapenems by means of matrix-associated laser 
desorption-ionization time of the span mass spectrometry) (MALDI-TOF MS) produc-
tion of carbapenem from the isolated isolates is confirmed for several hours. Isolates of 
K. pneumoniae were characterized by high cross-resistance and associated resistance. 
In 100 % of cases, isolates were resistant to Amikatin, Cephepin, Cephaperazon, Cefa-
toxim, Ceftazidim, and to a pair of antibacterial preparations: Ceftazidim and Avibaktam.
In 61.1 % of the cases, the resulting K. Pneumoniae isolates were resistant to gen-
tamicin and thigecyclin, with 50 % being either Impenemic-resistant or indifferent. It is 
55.6 % resistant to Meropinium and Polymyxin. At the same time, it is 38.9 % Isolates of 
K. Pneumoniae are absolutely indifferent to Meropinium and Tigecyclin. The frequency 
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Fig. 1. Age of study group
Fig. 2. Types of intervention
Fig. 3. The administration of antibacterial drugs
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of stability and intermediate sensitivity to c-trimoxazole was 88.9 %, gentamicin 83.3 %, 
imipenem 100 %, meropenium 94.4 %, and tihecycline 100 %.
A relatively high sensitivity level was maintained for polymyxin B (44.4 %) and a com-
bination of aztreonam and avibaktam (66.7 %). The best results for antibacterial therapy 
were found in the pair Aztreonam and Avibaktam, but even to them resistance is observed 
in 11.1 % of cases (Table). 
Table. Minimum inhibiting concentrations (MIC) of K. pneumoniae
Antibiotic name Breakpoints %R %I %S MIC Range
Amikacin S<=8 R>=32 100 0 0 64 — 128
Cefepime S<=1 R>=8 100 0 0 64 — 512
Cefoperazone S<=1 R>=4 100 0 0 0.256 — 512
Cefotaxime S<=1 R>=4 100 0 0 64 — 512 
Ceftazidime S<=1 R>=8 100 0 0 256 — 512 
Ciprofloxacin S<=.25 R>=1 100 0 0 64 — 512 
Gentamicin S<=2 R>=8 61.1 22.2 16.7 0.25 — 512 
Imipenem S<=2 R>=8 50 50 0 2 — 256 
Meropenem S<=2 R>=16 55.6 38.9 5.6 2 — 64 
Polymixin B S<=2 R>=4 55.6 0 44.4 0.25 — 256 
Tigecycline S<=0.5 R>=1 61.1 38.9 0 0.5 — 32 
Trimethoprim/Sulfamethoxazole S<=2 R>=8 88.9 0 11.1 0.5 — 256 
Ceftazidime/Avibactam S<=8 R>=16 100 0 0 256 — 256 
Aztreonam/Avibactam S<=1 R>=8 11.1 22.2 66.7 0.125 — 128 
After a microbiological study, 52 isolates of K. pneumoniae were obtained, 53.8 % of 
isolates had a hypermucoid phenotype and 98 % had carbapenemases: blaNDM type — 
49 (92 %), blaNDM+OXA-48-like — 3 (8 %) (Fig. 4). Isolates with two new phenotypes 
Fig. 4. Minimum inhibiting concentrations of K. pneumoniae
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have been isolated (no. 2511 and no. 2512). The isolates of 2512 LD50 are 10*2 BAC/ml. 
Plasmids Incfib(Mar), Inchi1b, Incr were found in isolates 2512. Secreted plasmid Incr in 
strain 2512 encoded resistance to fluoroquinolone: aac(6’)-Ib-cr and to β-lactam antibiot-
ics: blaTEM-1B. 
Discussion
Thus, the K. pneumoniae isolates produced are of particular importance, as almost all 
β-lactam resistance occurs due to carbapenemase metal-β-lactamase. Furthermore, the 
isolated strains producing carbapenemases possess mechanisms of resistance to a wide 
range of antimicrobial preparations, and the infections caused by carbapenemazo-pro-
ducing enterobacteria have a high lethality level.
Of particular concern is this type of metal-β-lactamase, carbapenemase, as it can 
cause resistance to almost all β-lactams. Furthermore, the strains producing carbapen-
emases often have mechanisms of resistance to a wide range of antimicrobial preparations, 
and the infections caused by carbapenemazo-producing enterobacteria are characterized 
by a high lethality level.
Until recently, the propagation of plasmid-encoded MBL was a minor threat in most 
geographical regions, even in countries with sporadic enzyme outbreaks, such as VIM-1 in 
Greece, IMP-8 in Taiwan, and IMP-1 in Japan. However, Mbls became more threatening 
after the NDM-1 zinc-containing carbapenemase was identified in 2009 from an isolate 
originating from New Delhi, India. As opposite to other MBL systems, NDM-1 quickly 
spread globally, being the predominant carbapenemase in the Indian subcontinent. Of 
great importance is the prevalence of the blaNDM gene, which has been identified in wa-
ter samples and in the environment in India.
The results indicate that K. pneumoniae is a strain that is polyresistant to the antibac-
terial preparations used and encoded with plasmids by Incfib(Mar), Inchi1b and Incr in 
the K. pneumonia strain. Incr’s isolated plasmid encodes resistance to fluoroquinolone: 
aac(6’)-Ib-cr and to β-lactam antibiotics: blaTEM-1B. 
At present, a-lactam agent that inhibits a wide range of pathogens, including non-
fergent and anaerobic pathogens has yet to be identified. This is partly due to an increase 
in the number of microorganisms with multiple drug stability producing Mbls and / or 
OXA-48 carbapenemases in combination with lactamases of different classes and the lack 
of an effective inhibitor of all enzymes.
Thus, it is possible that MBL, rather than serine-lactamases, may become the pre-
dominant carbapenemase in bacteria with multiple drug resistance. It is also possible that 
lactamase-resistant agents, such as cephiderocol (S-649266), or lactam-free agents, such 
as plazomycin, omadacyclin, or eraavacycline, provide reliable and safe therapeutic alter-
natives against the most carbapen-resistant microorganisms.
In conclusion, it should be noted that lactamases, which are among the “oldest en-
zymes”, have proved to be the most studied with one side and with the other the most 
problematic determinants of resistance to antibiotics. The fact that genes encoding many 
lactamases are “travelling” together on movable elements  — plasmids, determines the 
possibility of transmission of resistance factors for other classes of antibiotics. Additional 
unique lactamases with unusual properties can be expected to be identified due to the 
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widespread distribution of these genes both in the environment and in the hospital envi-
ronment due to the extensive use and use of antibiotics.
Therefore, the identification and subsequent monitoring of microbial agents in each 
health facility should be more demanding, with a description of each sub-unit on the cir-
culating microbial unit. This will help to provide a scientific basis for the development of 
new antimicrobial agents that will help to avoid new outbreaks of infections.
Conclusion
The findings of the study indicate the need for continuous epidemiological surveil-
lance of the circulation of strains in multi-hospital facilities in order to prevent nosocomi-
al infections. There is also a need to develop timely tactics for effective antibiotic therapy 
and adequate preventive measures.
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